• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CYP3A4 和 CYP3A5 对长春瑞滨代谢的相对贡献。

The relative contributions of CYP3A4 and CYP3A5 to the metabolism of vinorelbine.

机构信息

Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.

出版信息

Drug Metab Dispos. 2013 Sep;41(9):1651-61. doi: 10.1124/dmd.113.051094. Epub 2013 Jun 18.

DOI:10.1124/dmd.113.051094
PMID:23780963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3876810/
Abstract

Vinorelbine is a semisynthetic vinca alkaloid used in the treatment of advanced breast and non-small cell lung cancers. Vincristine, a related vinca alkaloid, is 9-fold more efficiently metabolized by CYP3A5 than by CYP3A4 in vitro. This study quantified the relative contribution of CYP3A4 and CYP3A5 to the metabolism of vinorelbine in vitro using cDNA-expressed human cytochrome P450s (P450s) and human liver microsomes (HLMs). CYP3A4 and CYP3A5 were identified as the P450s capable of oxidizing vinorelbine using a panel of human enzymes and selective P450 inhibitors in HLMs. For CYP3A4 coexpressed with cytochrome b5 (CYP3A4+b5) and CYP3A5+b5, the Michaelis-Menten constants for vinorelbine were 2.6 and 3.6 μM, respectively, but the Vmax of 1.4 pmol/min/pmol was common to both enzymes. In HLMs, the intrinsic clearance of vinorelbine metabolism was highly correlated with CYP3A4 activity, and there was no significant difference in intrinsic clearance between CYP3A5 high and low expressers. When radiolabeled vinorelbine substrate was used, there were clear qualitative differences in metabolite formation fingerprints between CYP3A4+b5 and CYP3A5+b5 as determined by NMR and mass spectrometry analysis. One major metabolite (M2), a didehydro-vinorelbine, was present in both recombinant and microsomal systems but was more abundant in CYP3A4+b5 incubations. We conclude that despite the equivalent efficiency of recombinant CYP3A4 and CYP3A5 in vinorelbine metabolism the polymorphic expression of CYP3A5, as shown by the kinetics with HLMs, may have a minimal effect on systemic clearance of vinorelbine.

摘要

长春瑞滨是一种半合成长春碱类药物,用于治疗晚期乳腺癌和非小细胞肺癌。长春新碱是一种相关的长春碱类药物,在体外比 CYP3A4 更有效地被 CYP3A5 代谢 9 倍。本研究使用 cDNA 表达的人细胞色素 P450(P450)和人肝微粒体(HLM),定量研究了 CYP3A4 和 CYP3A5 对长春瑞滨体外代谢的相对贡献。使用 HLMs 中的人酶和选择性 P450 抑制剂鉴定 CYP3A4 和 CYP3A5 为能够氧化长春瑞滨的 P450。对于与细胞色素 b5(CYP3A4+b5)共表达的 CYP3A4 和 CYP3A5+b5,长春瑞滨的米氏常数分别为 2.6 和 3.6 μM,但两种酶的 Vmax 均为 1.4 pmol/min/pmol。在 HLMs 中,长春瑞滨代谢的内在清除率与 CYP3A4 活性高度相关,CYP3A5 高表达者和低表达者之间的内在清除率没有显著差异。当使用放射性标记的长春瑞滨底物时,通过 NMR 和质谱分析,在 CYP3A4+b5 和 CYP3A5+b5 之间清楚地观察到代谢产物形成指纹的定性差异。一种主要代谢产物(M2),一种脱氢长春瑞滨,在重组和微粒体系统中均存在,但在 CYP3A4+b5 孵育中更为丰富。我们得出结论,尽管重组 CYP3A4 和 CYP3A5 在长春瑞滨代谢中的效率相当,但 CYP3A5 的多态性表达,如与 HLMs 的动力学所示,可能对长春瑞滨的全身清除率影响最小。

相似文献

1
The relative contributions of CYP3A4 and CYP3A5 to the metabolism of vinorelbine.CYP3A4 和 CYP3A5 对长春瑞滨代谢的相对贡献。
Drug Metab Dispos. 2013 Sep;41(9):1651-61. doi: 10.1124/dmd.113.051094. Epub 2013 Jun 18.
2
Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes.CYP3A5表达对长春新碱在人肝微粒体中代谢的影响。
J Pharmacol Exp Ther. 2007 May;321(2):553-63. doi: 10.1124/jpet.106.118471. Epub 2007 Feb 1.
3
Metabolism of quetiapine by CYP3A4 and CYP3A5 in presence or absence of cytochrome B5.喹硫平在细胞色素B5存在或不存在的情况下由CYP3A4和CYP3A5进行的代谢。
Drug Metab Dispos. 2009 Feb;37(2):254-8. doi: 10.1124/dmd.108.023291. Epub 2008 Nov 20.
4
In Vitro Kinetic Characterization of Axitinib Metabolism.阿昔替尼代谢的体外动力学特征
Drug Metab Dispos. 2016 Jan;44(1):102-14. doi: 10.1124/dmd.115.065615. Epub 2015 Oct 28.
5
CYP3A4 is mainly responsibile for the metabolism of a new vinca alkaloid, vinorelbine, in human liver microsomes.细胞色素P450 3A4主要负责在人肝微粒体中对一种新型长春花生物碱长春瑞滨进行代谢。
Drug Metab Dispos. 2000 Sep;28(9):1121-7.
6
Relative contributions of cytochrome CYP3A4 versus CYP3A5 for CYP3A-cleared drugs assessed in vitro using a CYP3A4-selective inactivator (CYP3cide).使用CYP3A4选择性灭活剂(CYP3cide)在体外评估CYP3A清除的药物时,细胞色素CYP3A4与CYP3A5的相对贡献。
Drug Metab Dispos. 2014 Jul;42(7):1163-73. doi: 10.1124/dmd.114.057000. Epub 2014 Apr 15.
7
The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.人cDNA表达的以及人肝微粒体细胞色素P450 1A2和3A4对黄曲霉毒素B1的氧化动力学。
Toxicol Appl Pharmacol. 1996 Dec;141(2):595-606. doi: 10.1006/taap.1996.0326.
8
Assessment of the impact of CYP3A polymorphisms on the formation of α-hydroxytamoxifen and N-desmethyltamoxifen in human liver microsomes.评估 CYP3A 多态性对人肝微粒体中 α-羟他莫昔芬和 N-去甲基他莫昔芬形成的影响。
Drug Metab Dispos. 2012 Feb;40(2):389-96. doi: 10.1124/dmd.111.039388. Epub 2011 Nov 17.
9
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.细胞色素P450 3A4、细胞色素P450 3A5和细胞色素P450 3A7的比较代谢能力。
Drug Metab Dispos. 2002 Aug;30(8):883-91. doi: 10.1124/dmd.30.8.883.
10
Cytochrome P450 3A4 and CYP3A5-Catalyzed Bioactivation of Lapatinib.细胞色素P450 3A4和CYP3A5催化的拉帕替尼生物活化作用
Drug Metab Dispos. 2016 Oct;44(10):1584-97. doi: 10.1124/dmd.116.070839. Epub 2016 Jul 22.

引用本文的文献

1
The Wnt/β-catenin signaling pathway plays a role in drug-induced liver injury by regulating cytochrome P450 2E1 expression.Wnt/β-连环蛋白信号通路通过调节细胞色素P450 2E1的表达在药物性肝损伤中发挥作用。
Toxicol Res. 2023 Apr 14;39(3):443-453. doi: 10.1007/s43188-023-00180-6. eCollection 2023 Jul.
2
Chitosan-Coated Liposomes: The Strategy to Reduce Intestinal Toxicity and Improve Bioavailability of Oral Vinorelbine.壳聚糖包被脂质体:降低口服长春瑞滨肠道毒性并提高其生物利用度的策略
AAPS PharmSciTech. 2022 Jun 10;23(5):163. doi: 10.1208/s12249-022-02308-7.
3
Pharmacogenetic Gene-Drug Associations in Pediatric Burn and Surgery Patients.儿科烧伤和手术患者的药物遗传学基因-药物关联。
J Burn Care Res. 2022 Sep 1;43(5):987-996. doi: 10.1093/jbcr/irac062.
4
Pogostone inhibits the activity of CYP3A4, 2C9, and 2E1 .泊洛沙姆抑制 CYP3A4、2C9 和 2E1 的活性。
Pharm Biol. 2021 Dec;59(1):532-536. doi: 10.1080/13880209.2021.1917630.
5
Interaction between phytotherapy and oral anticancer agents: prospective study and literature review.草药疗法与口服抗癌药物的相互作用:前瞻性研究和文献回顾。
Med Oncol. 2019 Apr 16;36(5):45. doi: 10.1007/s12032-019-1267-z.
6
Identification of Cytochrome P450 Polymorphisms in Burn Patients and Impact on Fentanyl Pharmacokinetics: A Pilot Study.烧伤患者细胞色素P450多态性的鉴定及其对芬太尼药代动力学的影响:一项初步研究
J Burn Care Res. 2019 Jan 1;40(1):91-96. doi: 10.1093/jbcr/iry053.
7
Amenamevir: Studies of Potential CYP3A-Mediated Pharmacokinetic Interactions With Midazolam, Cyclosporine, and Ritonavir in Healthy Volunteers.阿美纳韦:在健康志愿者中进行的与咪达唑仑、环孢素和利托那韦潜在 CYP3A 介导的药代动力学相互作用的研究。
Clin Pharmacol Drug Dev. 2018 Nov;7(8):844-859. doi: 10.1002/cpdd.586. Epub 2018 Jul 25.
8
Inhibition of cytochrome P450 3A by acetoxylated analogues of resveratrol in in vitro and in silico models.白藜芦醇乙酰化类似物在体外和计算模型中对细胞色素 P450 3A 的抑制作用。
Sci Rep. 2016 Aug 17;6:31557. doi: 10.1038/srep31557.
9
Editor's Highlight: Neonatal Activation of the Xenobiotic-Sensors PXR and CAR Results in Acute and Persistent Down-regulation of PPARα-Signaling in Mouse Liver.编辑亮点:新生儿期异生素传感器PXR和CAR的激活导致小鼠肝脏中PPARα信号的急性和持续性下调。
Toxicol Sci. 2016 Oct;153(2):282-302. doi: 10.1093/toxsci/kfw127. Epub 2016 Jul 13.
10
Functioning of drug-metabolizing microsomal cytochrome P450s: In silico probing of proteins suggests that the distal heme 'active site' pocket plays a relatively 'passive role' in some enzyme-substrate interactions.药物代谢微粒体细胞色素P450的功能:蛋白质的计算机模拟探测表明,远端血红素“活性位点”口袋在某些酶-底物相互作用中发挥相对“被动的作用”。
In Silico Pharmacol. 2016 Dec;4(1):2. doi: 10.1186/s40203-016-0016-7. Epub 2016 Feb 19.

本文引用的文献

1
Rapid and sensitive determination of vinorelbine in human plasma by liquid chromatography-tandem mass spectrometry and its pharmacokinetic application.采用液相色谱-串联质谱法快速灵敏测定人血浆中长春瑞滨及其药代动力学应用。
J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Mar 15;879(9-10):662-8. doi: 10.1016/j.jchromb.2011.01.039. Epub 2011 Feb 20.
2
Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia.CYP3A5 表达基因型低的急性淋巴细胞白血病患儿长春新碱神经毒性风险增加。
Pediatr Blood Cancer. 2011 Mar;56(3):361-7. doi: 10.1002/pbc.22845. Epub 2010 Nov 11.
3
Metabolism pathway of vinorelbine (Navelbine) in human: characterisation of the metabolites by HPLC-MS/MS.长春瑞滨(诺维本)在人体内的代谢途径:通过高效液相色谱-串联质谱法对代谢产物进行表征
J Pharm Biomed Anal. 2008 May 12;47(1):47-58. doi: 10.1016/j.jpba.2007.12.006. Epub 2007 Dec 15.
4
Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients.种族对小儿急性淋巴细胞白血病患者长春新碱相关神经毒性的影响。
Pediatr Blood Cancer. 2008 Apr;50(4):769-71. doi: 10.1002/pbc.21435.
5
MDR1 single nucleotide polymorphisms predict response to vinorelbine-based chemotherapy in patients with non-small cell lung cancer.多药耐药基因1单核苷酸多态性预测非小细胞肺癌患者对长春瑞滨为主的化疗的反应。
Respiration. 2008;75(4):380-5. doi: 10.1159/000108407. Epub 2007 Sep 12.
6
CYP450 polymorphisms predict clinic outcomes to vinorelbine-based chemotherapy in patients with non-small-cell lung cancer.细胞色素P450基因多态性可预测非小细胞肺癌患者基于长春瑞滨化疗的临床结局。
Acta Oncol. 2007;46(3):361-6. doi: 10.1080/02841860600902197.
7
Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes.CYP3A5表达对长春新碱在人肝微粒体中代谢的影响。
J Pharmacol Exp Ther. 2007 May;321(2):553-63. doi: 10.1124/jpet.106.118471. Epub 2007 Feb 1.
8
Selective metabolism of vincristine in vitro by CYP3A5.CYP3A5在体外对长春新碱的选择性代谢作用。
Drug Metab Dispos. 2006 Aug;34(8):1317-27. doi: 10.1124/dmd.106.009902. Epub 2006 May 5.
9
Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer.癌症患者中长春瑞滨药代动力学和药效学的预测因素。
J Clin Oncol. 2006 Jun 1;24(16):2448-55. doi: 10.1200/JCO.2005.02.1295. Epub 2006 May 1.
10
Predicting vinorelbine disposition and toxicity: does BSA provide more than a "bad statistical association"?预测长春瑞滨的处置和毒性:体表面积所提供的信息是否不止于“不良统计关联”?
J Clin Oncol. 2006 Jun 1;24(16):2412-3. doi: 10.1200/JCO.2005.05.4494. Epub 2006 May 1.